Amplisol

Amplisol may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Amplisol

Ampicillin

Ampicillin sodium salt (a derivative of Ampicillin) is reported as an ingredient of Amplisol in the following countries:

• Italy

International Drug Name Search

Magnésium Véto Veine

Magnésium Véto Veine may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Magnésium Véto Veine

Magnesium Sulfate

Magnesium Sulfate is reported as an ingredient of Magnésium Véto Veine in the following countries:

• France

International Drug Name Search

Provigil

Provigil is a brand name of modafinil, approved by the FDA in the following formulation(s):

PROVIGIL (modafinil - tablet; oral)

• 
  Manufacturer: CEPHALON
  
  Approval date: December 24, 1998
  
  Strength(s): 100MG, 200MG ^[RLD]

Has a generic version of Provigil been approved?

No. There is currently no therapeutically equivalent version of Provigil available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Provigil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pharmaceutical formulations of modafinil
  Patent 7,297,346
  Issued: November 20, 2007
  Inventor(s): Corvari; Vincent & Grandolfi; George & Parikh; Alpa
  Assignee(s): Cephalon Inc.
  The present invention is related to compositions of modafinil, including compositions of modafinil and one or more diluents, disintegrants, binders and lubricants, and the processes for their preparation thereof.
  
  Patent expiration dates:
  
  
  • November 29, 2023
    
    ✓ 
    Drug product
  
  
  
  • May 29, 2024
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Acetamide derivative having defined particle size
  Patent RE37516
  Issued: January 15, 2002
  Inventor(s): Peter E.; Grebow & Vincent; Corvari & David; Stong
  Assignee(s): Cephalon, Inc.
  Pharmaceutical compositions comprising modafinil in the form of particles of defined size. The particle size of modafinil can have a significant effect on the potency and safety profile of the drug.
  
  Patent expiration dates:
  
  
  • October 6, 2014
    
    ✓ 
    Patent use: IMPROVED WAKEFULNESS IN PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH NARCOLEPSY
  
  
  
  • April 6, 2015
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Provigil Consumer Information (Drugs.com)
• Provigil Consumer Information (Wolters Kluwer)
• Provigil Consumer Information (Cerner Multum)
• Provigil Advanced Consumer Information (Micromedex)
• Provigil AHFS DI Monographs (ASHP)
• Modafinil Consumer Information (Wolters Kluwer)
• Modafinil Consumer Information (Cerner Multum)
• Modafinil Advanced Consumer Information (Micromedex)
• Modafinil AHFS DI Monographs (ASHP)

Bumetin

Bumetin may be available in the countries listed below.

Ingredient matches for Bumetin

Trimebutine

Trimebutine maleate (a derivative of Trimebutine) is reported as an ingredient of Bumetin in the following countries:

• Colombia


• Venezuela

International Drug Name Search

Marcaine Spinal

In the US, Marcaine Spinal (bupivacaine systemic) is a member of the drug class local injectable anesthetics and is used to treat Cesarean Section and Local Anesthesia.

US matches:

• Marcaine Spinal Solution


• Marcaine Spinal

Ingredient matches for Marcaine Spinal

Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Marcaine Spinal in the following countries:

• Czech Republic


• Israel


• New Zealand


• Romania


• Serbia


• Thailand

International Drug Name Search

Alendron-Hexal

Alendron-Hexal may be available in the countries listed below.

Ingredient matches for Alendron-Hexal

Alendronic Acid

Alendronic Acid is reported as an ingredient of Alendron-Hexal in the following countries:

• Luxembourg

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendron-Hexal in the following countries:

• Czech Republic


• Germany


• Hungary

International Drug Name Search

Ptinolin

Ptinolin may be available in the countries listed below.

Ingredient matches for Ptinolin

Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ptinolin in the following countries:

• Greece

International Drug Name Search

Codical

Codical may be available in the countries listed below.

Ingredient matches for Codical

Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Codical in the following countries:

• Israel

International Drug Name Search

Captalin

Captalin may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Captalin

Spiramycin

Spiramycin is reported as an ingredient of Captalin in the following countries:

• Belgium


• France


• Italy


• Luxembourg


• Portugal

International Drug Name Search

Neuchlonic

Neuchlonic may be available in the countries listed below.

Ingredient matches for Neuchlonic

Nitrazepam

Nitrazepam is reported as an ingredient of Neuchlonic in the following countries:

• Japan

International Drug Name Search

Deferoxamine

In some countries, this medicine may only be approved for veterinary use.

In the US, Deferoxamine (deferoxamine systemic) is a member of the following drug classes: antidotes, chelating agents and is used to treat Iron Poisoning - Acute and Iron Poisoning - Chronic.

US matches:

• Deferoxamine


• Deferoxamine Injection


• Deferoxamine Mesylate

Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

V03AC01

CAS registry number (Chemical Abstracts Service)

0000070-51-9

Chemical Formula

C25-H48-N6-O8

Molecular Weight

560

Therapeutic Category

Antidote: Chelating agent

Chemical Name

Butanediamide, N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxy-

Foreign Names

• Deferoxaminum (Latin)
• Deferoxamin (German)
• Déferoxamine (French)
• Deferoxamina (Spanish)

Generic Names

• Deferoxamina (OS: DCIT)
• Deferoxamine (OS: USAN)
• Déféroxamine (OS: DCF)
• Desferrioxamine (OS: BAN)
• Desferrin (IS)
• Desferroxiamin B (IS)
• DFOA (IS)
• Deferoxamine Hydrochloride (OS: USAN)
• Ba 29837 (IS)
• Deferoxamine Mesilate (OS: JAN)
• Deferoxamine Mesylate (OS: USAN)
• Desferrioxamine Mesilate (OS: BANM)
• Ba 33112 (IS)
• Deferoxamine methanesulfonate (IS)
• Desferrioxamine Mesilate (IS)
• DFOM (IS)
• Déféroxamine (mésilate de) (PH: Ph. Eur. 6)
• Deferoxamine Mesilate (PH: Ph. Eur. 6, Ph. Int. 4, JP XV)
• Deferoxamine Mesylate (PH: USP 32)
• Deferoxamini mesilas (PH: Ph. Int. 4, Ph. Eur. 6)
• Deferoxaminmesilat (PH: Ph. Eur. 6)
• Desferrioxamine Mesilate (PH: BP 2010)

Brand Names

• Desferal
  Novartis, Ghana; Novartis, Guyana; Novartis, India; Novartis, Kenya; Novartis, Libya; Novartis, Nigeria; Novartis, Russian Federation; Novartis, Sudan; Novartis, Turkey; Novartis, Tanzania; Novartis, Zimbabwe



• Desféral
  Novartis, Tunisia



• Deferoxamine mesylate
  APP, United States



• Desferal
  Novartis, Czech Republic



• Deferoxamine mesylate
  Bedford, United States; Hospira, United States; Teva USA, United States; Watson, United States



• Deferoxamine-Teva
  Biogal, Israel



• Desferal
  EU-Pharma, Netherlands; Euro, Netherlands; Novartis, Argentina; Novartis, Austria; Novartis, Australia; Novartis, Belgium; Novartis, Bulgaria; Novartis, Bahrain; Novartis, Brazil; Novartis, Canada; Novartis, Switzerland; Novartis, Chile; Novartis, China; Novartis, Colombia; Novartis, Germany; Novartis, Denmark; Novartis, Finland; Novartis, United Kingdom; Novartis, Greece; Novartis, Hong Kong; Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Italy; Novartis, Japan; Novartis, Sri Lanka; Novartis, Luxembourg; Novartis, Malta; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Sweden; Novartis, Slovakia; Novartis, Thailand; Novartis, Taiwan; Novartis, United States; Novartis, Vietnam; Novartis, South Africa



• Desféral
  Novartis, France



• Desferal (veterinary use)
  Novartis Animal Health, United Kingdom



• Desferin
  Novartis, Spain



• Desferrioxamine Mesilate
  Hospira, Canada



• Desferrioxamine Mesylate DBL
  Hospira, Australia; Hospira, New Zealand; Hospira, Singapore; Mayne, Hong Kong



• Talifer
  Lemery, Sri Lanka

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Prop.INN	Proposed International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

SPMC Frusemide

SPMC Frusemide may be available in the countries listed below.

Ingredient matches for SPMC Frusemide

Furosemide

Furosemide is reported as an ingredient of SPMC Frusemide in the following countries:

• Sri Lanka

International Drug Name Search